Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database
PRINCETON, N.J.--(BUSINESS WIRE)--May 23, 2007 - Cytogen Corporation (NASDAQ: CYTO) today reported the publication of a review validating the utility of its ProChart(TM) database to help define the function of the WW domain-containing oxidoreductase (WWOX), an important tumor suppressor gene with k...Autochartist Subscription Options
... added Auto Chartist to their product range, available under the name ProChart. ProChart includes both FX and Equities. Want to try ProChart free for 21 days? ...MAP OF WW PROTEIN DOMAIN HELPS TARGET HEALTH PROBLEMS.
The new ProChart Database of protein interactions in the human bodyhas been ... In March, AxCell introduced ProChart in six cities across the United States ...Cytogen Corporation Reports Publication Validating the Utility of its ...
... Publication Validating the Utility of its Proprietary ProChart(TM) Database ... the utility of its ProChart™ database to help define the function of the WW ...